Rep. Craig Introduces Bill to Cap Monthly Insulin Costs at $35 for Private Insurance
This bill is currently sitting in three different House committees where it must be reviewed before it can move forward. Nothing has happened with the bill since November 2025, which means it has been stalled for about seven months. Most bills like this do not receive a committee vote and do not move further in the process.
While insulin caps have broad public support and already exist for Medicare, extending these limits to the private insurance market often faces pushback in a divided Congress.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 1488 (118th), which died when its Congress ended.
H.R. 1488 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Small business owners who sponsor group health plans would be required to offer insulin at the capped cost-sharing rate. While this helps employees who use insulin, it could modestly increase premiums or plan costs for small employers, since insurers may shift the cost of lower copays into higher overall premiums. The impact depends on how insurers and PBMs adjust pricing.
“a group health plan or health insurance issuer offering group or individual health insurance coverage shall provide coverage of selected insulin products”
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
A new bipartisan proposal in Congress, often referred to as the Affordable Insulin Now Act, aims to extend the $35 monthly cap to everyone, including those with private insurance. The plan builds on existing Medicare savings to expand relief to millions who currently pay far more out of pocket.
Starting January 1, 2026, a new state law (SB 40) will cap insulin out-of-pocket costs at $35 for millions of privately insured Californians. The law bars insurers from requiring patients to meet deductibles before the cap kicks in, mirroring federal efforts to expand the Medicare cap.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Affordable Insulin Now Act
Analysis generated by AI. Always verify with official sources.